Publicacions en què col·labora amb DANIEL MONLEON SALVADO (26)

2024

  1. Metabolic analysis using HR-MAS in prostate tissue for prostate cancer diagnosis

    Prostate, Vol. 84, Núm. 6, pp. 549-559

2023

  1. Altered Lipid Moieties and Carbonyls in a Wistar Rat Dietary Model of Subclinical Fatty Liver: Potential Sex-Specific Biomarkers of Early Fatty Liver Disease?

    Antioxidants, Vol. 12, Núm. 10

  2. Cardiovascular risk of metabolically healthy obesity in two european populations: Prevention potential from a metabolomic study

    Cardiovascular diabetology, Vol. 22, Núm. 1, pp. 82

2022

  1. Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: The Hortega Study

    Redox Biology, Vol. 52

  2. Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain

    International Journal of Behavioral Nutrition and Physical Activity, Vol. 19, Núm. 1

  3. Lipoprotein profiles of fat distribution and its association with insulin sensitivity

    Frontiers in Endocrinology, Vol. 13

  4. METABOLOMIC CHARACTERIZATION OF THE EARLY PROGRESSION OF CARDIOMETABOLIC DISEASE IN A HIGH FAT AND SUCROSE DIET RAT MODEL

    Journal of hypertension, Vol. 40, pp. e226

  5. Rodent models and metabolomics in non-alcoholic fatty liver disease: What can we learn?

    World Journal of Hepatology, Vol. 14, Núm. 2, pp. 304-318

  6. Sex Dimorphism in the Metabolome of Metabolic Syndrome in Morbidly Obese Individuals

    Metabolites, Vol. 12, Núm. 5

  7. THE CONSEQUENCES OF METABOLIC SYNDROME, SEX AND AGE ON THE METABOLOME AND EPIGENOME MUTUAL REGULATION: THE EPIGENETIC DRIFT IN SEVERE OBESITY

    Journal of hypertension, Vol. 40, pp. e269

2021

  1. Bacterial metabolites trimethylamine N-oxide and butyrate as surrogates of small intestinal bacterial overgrowth in patients with a recent decompensated heart failure

    Scientific Reports, Vol. 11, Núm. 1

2019

  1. Diastolic left ventricular function in relation to circulating metabolic biomarkers in a population study

    European Journal of Preventive Cardiology, Vol. 26, Núm. 1, pp. 22-32

  2. Hydrogen- and Methane-Based Breath Testing and Outcomes in Patients With Heart Failure

    Journal of Cardiac Failure, Vol. 25, Núm. 5, pp. 319-327

  3. Two-Week Aflibercept or Erlotinib Administration Does Not Induce Changes in Intestinal Morphology in Male Sprague–Dawley Rats But Aflibercept Affects Serum and Urine Metabolic Profiles

    Translational Oncology, Vol. 12, Núm. 8, pp. 1122-1130

2018

  1. LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study

    International Journal of Cardiology, Vol. 264, pp. 172-178

  2. Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Chemotherapy-induced gastrointestinal toxicity is associated with changes in serum and urine metabolome and fecal microbiota in male Sprague–Dawley rats

    Cancer Chemotherapy and Pharmacology, Vol. 80, Núm. 2, pp. 317-332

  2. Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit

    PLoS ONE, Vol. 12, Núm. 5

  3. Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism

    Gut, Vol. 66, Núm. 4, pp. 620-632

  4. Peripheral blood mitochondrial DNA content in relation to circulating metabolites and inflammatory markers: A population study

    PLoS ONE, Vol. 12, Núm. 7